Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 4Phase 2/3 2Phase 2 2Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 4Head and Neck Neoplasms 3Pain 2Depression 2Breast Neoplasms 2Stomatitis 1Pancreatic Neoplasms 1Pain, Postoperative 1Mucositis 1Lung Neoplasms 1Choledocholithiasis 1Choledochal Cyst 1Cholangitis 1Cancer Pain 1Anxiety Disorders 1Agnosia 1

Interventions

Psilocybin 6Therapeutics 2Ketamine 2Exercise 2Venlafaxine Hydrochloride 1Vegetables 1Terminal Care 1Self-Management 1SLI381 1Psychotherapy 1Psychosocial Intervention 1Psychiatric Rehabilitation 1Professional Autonomy 1Niacin 1Mirtazapine 1Minocycline 1Methylphenidate 1Mental Status and Dementia Tests 1Melatonin 1Medical Marijuana 1Interpersonal Psychotherapy 1Injections 1Infliximab 1Gemcitabine 1Fruit 1Fluoxetine 1Ethanol 1Doxorubicin 1Donepezil 1Dignity Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Depression × Ketamine × Clear all
NCT03410446 2022-05-06

Study of Ketamine for Depression in Cancer Patients Receiving Palliative Care

University Health Network, Toronto

Phase 2 Completed
22 enrolled

Depression, Neoplasms

NCT01680172 2016-02-29

Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer

Mayo Clinic

Phase 2 Terminated
5 enrolled 6 charts

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡